NovAliX Joins Hands With Max Planck Institute on Cancer Pact

March 7, 2024

AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals

July 11, 2025

Zealand Pharma Presents Clinical Results From the Phase 3 Trial of Dasiglucagon

September 23, 2022

Must Read

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

April 23, 2026

Top 10 Biotech Companies to Watch in 2026

April 23, 2026

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

April 23, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

AstraZeneca Reports Phase 3 MIRANDA Trial Success for Tozorakimab in COPD

Travere’s Filspari becomes the first FDA-approved medication for FSGS

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

Revolution Meets Key Survival Goals With RAS Inhibitor In Important Trial

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Regulatory

Flynn Pharma and Pfizer fined 70M pounds for substantial price jump on epilepsy drug

Editor Picks

NovAliX Joins Hands With Max Planck Institute on Cancer Pact

AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals

Zealand Pharma Presents Clinical Results From the Phase 3 Trial of Dasiglucagon

Must Read

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Top 10 Biotech Companies to Watch in 2026

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Hot Topics

About Us

Follow Us